The primary objective of our centre is to translate recent huge advances in the basic understanding of the pathogenesis of coeliac disease to the clinic – to improve disease diagnostics, to implement novel treatments and to identify new therapeutic targets for this common disease.
The secondary objective is to become a clinical research site at the international forefront which will provide optimal patient care and which will be a unique training site for basic scientists and clinicians.
Identification of narrow T-cell phenotype in coeliac disease
May 13, 2019 4:06 PM
Post.doc Asbjørn Christophersen has spear-headed the work that lead to identification of a narrow phenotype of gluten specific CD4+ T cells. This cell subset is also present in other autoimmune conditions and could be a target for future disease therapy.
- Vacant positions Feb. 21, 2019 8:54 AM
Medisinbloggen: What is really gluten?
Dec. 20, 2018 11:14 PM
Gluten is a protein we have enjoyed for thousands of years. But if you have celiac disease, your body thinks that this protein is something dangerous. But what is gluten really?
Fine mapping of the wheat genome- one step closer to gluten free wheat
Sep. 6, 2018 7:56 AM
Through a massive, international collaborative effort, the entire genome of bread wheat has now been mapped. This makes it possible to in the future develop wheat strains that lack certain proteins, including the gluten proteins that are harmful for celiac disease patients.
- Author Correction: Gut microbiome structure and metabolic activity in inflammatory bowel disease Apr. 12, 2019 11:00 AM
- Long-term efficacy and safety of biosimilar infliximab (CT-P13) after switching from originator infliximab: open-label extension of the NOR-SWITCH trial Feb. 15, 2019 10:00 AM
- Gut Microbial Associations to Plasma Metabolites Linked to Cardiovascular Phenotypes and Risk Apr. 12, 2019 11:00 AM